NCT02689999View on ClinicalTrials.gov

The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2017

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG

Dexrabeprazole 10 mg Enteric-Coated Tablets

Trial Locations (3)

35100

Ege University Gastroenterology Department, Izmir

Unknown

Ankara University Gastroenterology Department, Ankara

On Dokuz Mayıs University Gastroenterology Department, Samsun

All Listed Sponsors
lead

Neutec Ar-Ge San ve Tic A.Ş

INDUSTRY

NCT02689999 - The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity | Biotech Hunter | Biotech Hunter